FATE
Fate Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.17
+0.00 +0.00%
🌙 3월 13일 5:15 PM ET (한국 3/14 06:15)
$1.16
-0.01 ▼ -0.85%
| Index | RUT | P/E | - | EPS (ttm) | -1.15 | Insider Own | 5.3% | Shs Outstand | 0.12B | Perf Week | -12.03% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | 1.94% | Insider Trans | -0.26% | Shs Float | 0.11B | Perf Month | - |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.28 | Inst Own | 70.78% | Short Float | 8.69% | Perf Quarter | 7.34% |
| Income | -0.14B | P/S | 20.46 | EPS this Y | 0.58% | Inst Trans | -0.35% | Short Ratio | 5.72 | Perf Half Y | 14.71% |
| Sales | 0.01B | P/B | 0.65 | EPS next 5Y | -1% | ROA | -35.89% | Short Interest | 9.56M | Perf YTD | 19.07% |
| Book/sh | 1.8 | P/C | 0.67 | EPS past 3/5Y | 26.67% 11.42% | ROE | -51.84% | 52W High | -39.69% ($1.94) | Perf Year | 24.01% |
| Cash/sh | 1.75 | P/FCF | - | Sales past 3/5Y | -58.98% -26.71% | ROIC | -48.6% | 52W Low | 76.99% ($0.66) | Perf 3Y | -78.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 30.42% | Gross Margin | -94.12% | Volatility(W/M) | 8.06% 9.22% | Perf 5Y | -98.76% |
| Dividend TTM | - | EV/Sales | 1.54 | Sales Y/Y TTM | -51.24% | Oper. Margin | -2222.45% | ATR (14) | 0.11 | Perf 10Y | -35.71% |
| Dividend Ex-Date | - | Quick Ratio | 5.79 | EPS Q/Q | 38.69% | Profit Margin | -2051.08% | RSI (14) | 40.53 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.79 | Sales Q/Q | -26.4% | SMA20 | -15.49% ($1.38) | Beta | 2.26 | Target Price | $4.94 |
| Payout | - | Debt/Eq | 0.38 | Earnings | 2000000 | SMA50 | -4.86% ($1.23) | Rel Volume | 1.11 | Prev Close | $1.17 |
| Employees | 161 | LT Debt/Eq | 0.35 | EPS/Sales Surpr. | 0.15% 2.42% | SMA200 | -0.91% ($1.18) | Avg Volume(3M) | 1.67M | Price | $1.17 |
| IPO | 2013/10/1 | Option/Short | Yes/Yes | Trades | 3146 | Volume | 1,860,787 | Change | - |
뉴스 로딩 중...